Speakers

John Xiong

Director, Head of In Vivo Pharmacology

LogicBio

Leah Byrne

Assistant Professor of Ophthalmology

University of Pittsburgh

Vivian Choi

Head of Global Gene Therapy Research

Takeda

Casey Case

Founder

Eleutheria

Michael Themis

Reader, PI of Gene Therapy and Genotoxicity

Brunel University London

Dirk Grimm

Professor

University of Heidelberg

Matthias Hebben

VP, Technology Development

LogicBio

Eric Kelsic

CEO

Dyno Therapeutics

Robert Kotin

Adjunct Professor

University of Massachusetts

Melissa Kotterman

Co-Founder; Vice President, Discovery & Engineering

4D Molecular Therapeutics

Ye Liu

Senior Director, Gene Transfer Technology, R&D

REGENXBIO

Abraham Scaria

CSO

IVERIC Bio

Matthew Fuller

Director, Vector Platform Research

Ultragenyx

Charles Shyng

Principal Scientist, AAV, Rare Disease

Pfizer

Genine Winslow

CEO

Chameleon Biosciences

Zhong Zhong

VP, Gene Therapy

Generation Bio

Kathy Ivey

Senior Director, Gene Therapy Research

Tenaya Therapeutics

Nicole Paulk

Assistant Professor, Biochemistry & Biophyiscs

University of California San Francisco

Hemant Khanna

Associate Professor

University of Massachusetts Medical School

Russell Monds

Director, Molecular Biology

Generation Bio

Neal Goodwin

Chief Scientific Officer

Teknova

Daozhan Yu

President & Chief Executive Officer

AAVnerGene